Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
World Acad Sci J
2020 Jan 01;26:. doi: 10.3892/wasj.2020.68.
Show Gene links
Show Anatomy links
Alignment of Alzheimer's disease amyloid β-peptide and klotho.
Lehrer S
,
Rheinstein PH
.
???displayArticle.abstract???
The cause of Alzheimer's disease (AD) is poorly understood. In 1991, the amyloid hypothesis postulated that β-amyloid (Aβ) accumulation is a key element. It follows that clearing the brain of Aβ would be beneficial, which has not been the case. Therefore, Aβ is likely a result, not a cause, of AD and may be protective rather than harmful. The apolipoprotein E4 (apoE4) allele is the strongest genetic risk factor for AD. Klotho (KL), encoded by the KL gene, may be another AD-related protein. FGF21 is a circulating endocrine hormone, mainly secreted by the liver, mostly during fasting. FGF21 acts by binding to its receptor FGFR1 and co-receptor β-klotho. FGF21 is neuroprotective and could delay onset of AD. In the present study, the KL protein structure was examined to determine whether it may interact with Aβ. Protein data bank (pdb) entries for klotho and Aβ were searched on the RCSB Protein Data Bank for β-KL and AD amyloid β-peptide. The protein structures were superimposed and aligned on PYMOL v2.3.4 with the super command, which super aligns two protein selections. To evaluate the conservation and alignment of the Aβ and KL genomes across species, BLAT, the Blast-Like Alignment Tool of the UCSC Genome Browser, was used. The amino acid residues phe76-val96 of KL aligned closely with residues asp7-asn27 of Aβ. Cross-species comparison of KL revealed a high degree of alignment and conservation in the chimp and 27 other primates; however, less alignment and conservation were observed in the mouse, dog and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish and lamprey. The current finding of amino acid residues phe76-val96 of klotho aligning closely with residues asp7-asn27 of Aβ suggests that Aβ can enhance the ability of klotho to draw FGF21 to regions of incipient neurodegeneration in AD. The problem arises with age. Older individuals do not heal or repair tissue damage as well as younger individuals. As neurodegeneration advances in an older individual, perhaps caused by neuroinflammation related to herpes simplex virus type 1, increasing amounts of amyloid are produced, forming an adhesive web, as the brain tries to hold the pathologic process in check. Meanwhile, the damage increases and spreads. Progressive neurodegeneration and cognitive decline are the outcome.
Figure 2. Solution structure of the Alzheimerâs disease Aβ-peptide.
Figure 3. Alignment of klotho peptide (green) domain 1 (D1) with Aβ (blue). FGF21 (red) is bound to domain 1.
Figure 4. Closeup of alignment. Pymol performed 6 cycles of calculations on 165 aligned atoms, with a final root mean square deviation of atomic positions (RMSD) of 1.792 à for 148 atoms. Amino acid residues phe76-val96 of klotho aligned closely with residues asp7-asn27 of Aβ.
Figure 5. Alignment of 42 amino acid residue human Aβ across species in the UCSC genome browser. There is a high degree of alignment and conservation of Aβ (chr 21q21.3) in the rhesus monkey and 27 other primates, but much less alignment and conservation in the mouse, dog, and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish and lamprey.
Figure 6. Alignment of human klotho across species in the UCSC genome browser. Results of the cross-species comparison of klotho show a high degree of alignment and conservation of human klotho (chr 13q13.1) in the chimp and 27 other primates, less alignment and conservation in the mouse, dog, and elephant, even less in the chicken, western clawed frog (Xenopus tropicalis), zebrafish and lamprey.
Belloy,
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
2020, Pubmed
Belloy,
Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
2020,
Pubmed
Bhagwat,
Using BLAT to find sequence similarity in closely related genomes.
2012,
Pubmed
Castellani,
Alzheimer disease pathology as a host response.
2008,
Pubmed
Castellani,
The complexities of the pathology-pathogenesis relationship in Alzheimer disease.
2014,
Pubmed
Crescenzi,
Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
2002,
Pubmed
Dubal,
Longevity Gene KLOTHO and Alzheimer Disease-A Better Fate for Individuals Who Carry APOE ε4.
2020,
Pubmed
Dubal,
Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice.
2015,
Pubmed
Gibbs,
Evolutionary and biomedical insights from the rhesus macaque genome.
2007,
Pubmed
Hardy,
Amyloid deposition as the central event in the aetiology of Alzheimer's disease.
1991,
Pubmed
Komaroff,
Can Infections Cause Alzheimer Disease?
2020,
Pubmed
Kuhn,
The UCSC genome browser and associated tools.
2013,
Pubmed
Kuro-o,
Klotho.
2010,
Pubmed
Kuro-O,
The Klotho proteins in health and disease.
2019,
Pubmed
Lee,
Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
2018,
Pubmed
Lehrer,
Mouse mammary tumor viral env sequences are not present in the human genome but are present in breast tumors and normal breast tissues.
2019,
Pubmed
Mangold,
Persistent Infection with Herpes Simplex Virus 1 and Alzheimer's Disease-A Call to Study How Variability in Both Virus and Host may Impact Disease.
2019,
Pubmed
Moir,
The antimicrobial protection hypothesis of Alzheimer's disease.
2018,
Pubmed
Moir,
Low Evolutionary Selection Pressure in Senescence Does Not Explain the Persistence of Aβ in the Vertebrate Genome.
2019,
Pubmed
Pickart,
Ubiquitin: structures, functions, mechanisms.
2004,
Pubmed
Soscia,
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
2010,
Pubmed
Taliyan,
Therapeutic Approaches to Alzheimer's Type of Dementia: A Focus on FGF21 Mediated Neuroprotection.
2019,
Pubmed